{
    "2018-05-23": [
        [
            {
                "time": "",
                "original_text": "调查，公司面临暂停上市风险",
                "features": {
                    "keywords": [
                        "调查",
                        "暂停上市",
                        "风险"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业季度策略：以低估值为主的防御型策略-深度挖掘低估值公司的修复行情",
                "features": {
                    "keywords": [
                        "医药生物",
                        "低估值",
                        "防御型策略",
                        "修复行情"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "看好中国｜健康中国——支持医药行业向好因素犹存",
                "features": {
                    "keywords": [
                        "健康中国",
                        "医药行业",
                        "向好因素"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【医药|杜佐远团队太平洋证券】一心堂(002727)：拟发行可转债保证未来顺利扩张，与白云山深度合作联动加强",
                "features": {
                    "keywords": [
                        "医药",
                        "一心堂",
                        "可转债",
                        "扩张",
                        "白云山",
                        "合作"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}